Intellectia LogoIntellectia
Product
Resources
Markets
News
Partner Program
Pricing
Log inTry for Free
Intellectia Logo
Log in
Intellectia Logo

Product

Features
Financial AI Agent
Stock Technical Analysis
Stock Monitor
Hedge Fund Tracker
AI Screener
Trading Strategies
AI Stock Picker
Swing Trading
Quant AI
Stock Chart Patterns
Daytrading Center
AI Earnings Prediction
Whales Auto Tracker
Backtesting Playground

Resources

Learn
Blog
Earnings
Tutorial
Help Center
Company
About Us
Contact
Press
Reward Program
Partner Program
Tools
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Compare
TradingView
SeekingAlpha

Markets

Trending Stocks
Hot Crypto
Trending News
All Stocks

News

Trading News
Overview
Top News
Daily Market Brief
Earnings
Latest
Newswire
Stock News
Crypto News
Monitor News
Partner ProgramPricing
Start for Free
  1. Home
    2. >
  2. Stock
    3. >
  3. OPCH
stocks logo

OPCH

-
collectAdd to Watchlistadvanced chartAdvanced Chart
$
0.000
0(0.000%)1D
collectadvanced chart
    Overview
    Forecast
    Valuation
    Earnings
High
--
Open
--
VWAP
--
Vol
--
Mkt Cap
--
Low
--
Amount
--
EV/EBITDA(TTM)
--
Total Shares
--
EV
--
EV/OCF(TTM)
--
P/S(TTM)
--
Financial AI Agent
Financial AI Agent

Market Estimates

Earnings Estimates
Earnings Estimates
Revenue
YoY Chg
EPS
YoYChg
FY2025Q4
FY2026Q1
FY2026Q2
1.46B
+8.08%
0.374
+6.94%
1.43B
+7.23%
0.336
+20%
1.52B
+7.17%
0.374
+20.65%
Estimates Revision
The market is revising Upward the revenue expectations for Option Care Health, Inc. (OPCH) for FY2025, with the revenue forecasts being adjusted by 0.23% over the past three months. During the same period, the stock price has changed by 2.77%.
Revenue Estimates for FY2025
Revise Upward
up Image
+0.23%
In Past 3 Month
EPS Estimates for FY2025
Revise Downward
down Image
-0.61%
In Past 3 Month
Stock Price
Go Up
up Image
+2.77%
In Past 3 Month
Wall Street analysts forecast OPCH stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for OPCH is 36.43 USD with a low forecast of 27.00 USD and a high forecast of 40.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
8 Analyst Rating
Wall Street analysts forecast OPCH stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for OPCH is 36.43 USD with a low forecast of 27.00 USD and a high forecast of 40.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
7 Buy
1 Hold
0 Sell
Strong Buy
Current: 29.895
sliders
Low
27.00
Averages
36.43
High
40.00
Current: 29.895
sliders
Low
27.00
Averages
36.43
High
40.00
TD Cowen
Hold
downgrade
$30 -> $27
2025-11-03
Reason
TD Cowen
Price Target
$30 -> $27
2025-11-03
downgrade
Hold
Reason
TD Cowen lowered the firm's price target on Option Care Health to $27 from $30 and keeps a Hold rating on the shares. The firm updated its model following Q3 results as Stelara uncertainty suggests a more cautious 2026 outlook.
Citizens JMP
Constantine Davides
Outperform
maintain
$38 -> $36
2025-10-31
Reason
Citizens JMP
Constantine Davides
Price Target
$38 -> $36
2025-10-31
maintain
Outperform
Reason
Citizens JMP analyst Constantine Davides lowered the firm's price target on Option Care Health to $36 from $38 and keeps an Outperform rating on the shares. Option Care's Q3 revenue and gross profit topped the firm's estimates, and Citizens tells investors in a research note that deployment toward Option's own stock is a prudent use of capital. The firm remains constructive on Option Care given the company's leading scale and market share, comprehensive therapeutic portfolio, differentiated platform, optionality from potential capital deployment and its meaningful discount to multiples paid in recent infusion transactions.
Morgan Stanley
Overweight
initiated
$35
2025-10-17
Reason
Morgan Stanley
Price Target
$35
2025-10-17
initiated
Overweight
Reason
Morgan Stanley initiated coverage of Option Care Health with an Overweight rating and $35 price target. The company is well positioned amid rising prevalence of chronic disease and focus on lower-cost care centers, the analyst tells investors in a research note. The firm says Option Care is a leader in the home and alternative-site infusion market, offering a critical solution to the healthcare system.
JMP Securities
Constantine Davides
Buy
Reiterates
$36
2025-04-22
Reason
JMP Securities
Constantine Davides
Price Target
$36
2025-04-22
Reiterates
Buy
Reason
Barrington Research
Michael Petusky
Buy
Maintains
$38
2025-04-21
Reason
Barrington Research
Michael Petusky
Price Target
$38
2025-04-21
Maintains
Buy
Reason
JP Morgan
Lisa Gill
Buy
Maintains
$40 → $41
2025-03-06
Reason
JP Morgan
Lisa Gill
Price Target
$40 → $41
2025-03-06
Maintains
Buy
Reason
See All Ratings

Valuation Metrics

The current forward P/E ratio for Option Care Health Inc (OPCH.O) is 20.13, compared to its 5-year average forward P/E of 28.02. For a more detailed relative valuation and DCF analysis to assess Option Care Health Inc 's fair value, click here.
  • Forward PE
  • Forward EV/EBITDA
  • Forward PS

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
Undervalued
5Y Average PE
28.02
Current PE
20.13
Overvalued PE
33.97
Undervalued PE
22.08

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average EV/EBITDA
15.34
Current EV/EBITDA
0.00
Overvalued EV/EBITDA
17.93
Undervalued EV/EBITDA
12.75

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average PS
1.13
Current PS
0.00
Overvalued PS
1.32
Undervalued PS
0.93
AI Stock Picker
AI Stock Picker

Financials

Annual
Quarterly
N/A
Total Revenue
N/A
Operating Profit
N/A
Net Income after Tax
N/A
EPS - Diluted
N/A
Free Cash Flow
N/A
Gross Profit Margin - %
N/A
FCF Margin - %
N/A
Net Margin - %
N/A
ROIC

Trading Trends

  • Insider
  • Hedge Fund
  • Congress Trading
Insider
Insiders areBuying! The selling amount has increased 887.63% over the last month.
Sold
Bought
Hedge Fund
Hedge Funds are Neutral. There are no significant trading trends over the last quarter.
Sold
Bought
Congress Trading
Congress are Neutral. There are no significant trading trends over the last month.
Sold
Bought
Insider
Insiders areBuying! The selling amount has increased 887.63% over the last month.
Sold
Bought
Intellectia AI SwingMax
Intellectia AI SwingMax

OPCH News & Events

Events Timeline

(ET)
2025-10-30
07:07:15
Option Care Health projects FY25 adjusted EPS between $1.68 and $1.72, in line with consensus of $1.71.
select
2025-10-30
07:05:41
Option Care Health announces Q3 adjusted EPS of 45 cents, surpassing consensus estimate of 43 cents.
select
2025-09-17 (ET)
2025-09-17
08:29:48
Barron's Labels Option Care Health as 'Undervalued'
select
link
Sign Up For More Events
Sign Up For More Events

News

[object Object]
Preview
2.0
11-25NASDAQ.COM
Option Care Health (OPCH) Stock Surpasses 200-Day Moving Average
  • 52 Week Range: OPCH's stock has a 52-week low of $22.29 and a high of $35.53, with the last trade recorded at $31.03.
  • Market Analysis: The article mentions other stocks that have recently crossed above their 200-day moving average.
  • Author's Perspective: The views expressed in the article are solely those of the author and do not necessarily represent Nasdaq, Inc.
  • Stock Performance Insight: The information provides insight into OPCH's stock performance within the context of its recent trading activity.
[object Object]
Preview
7.0
11-23Yahoo Finance
Does Option Care Health's 2025 Guidance Improvement Mitigate Stelara Biosimilar Challenges for OPCH Investors?

  • Company Strategy and Revenue Outlook: Option Care Health presented its strategy at the Jefferies London Healthcare Conference, addressing a projected revenue headwind of $60 million to $70 million in 2025 due to Stelara biosimilar discount changes, while simultaneously raising its full-year guidance for 2026.

  • Growth and Investment Confidence: The company expects growth in key financial metrics supported by the expansion of its advanced practitioner model, active share buybacks, and ongoing capital investments, indicating management's confidence despite industry challenges.

  • Market Risks and Profit Margins: Investors are advised to consider the impact of therapy mix shifts towards lower-margin drugs on profit margins, which could pose risks to the company's financial performance, even as management remains focused on profit growth and market expansion.

  • Future Projections and Fair Value Estimates: Option Care Health projects $6.9 billion in revenue and $306.2 million in earnings by 2028, requiring an annual growth rate of 8.8%, with fair value estimates for the stock ranging from $35.30 to $61.53 per share, reflecting varying investor opinions on future performance.

[object Object]
Preview
8.0
10-30NASDAQ.COM
Significant Options Activity on Wednesday: AVTR, EBAY, OPCH

  • eBay Options Trading: eBay Inc. experienced a significant options trading volume of 29,363 contracts, equating to about 2.9 million underlying shares, with notable activity in the $112 strike call option expiring on October 31, 2025.

  • Option Care Health Options Trading: Option Care Health Inc. recorded an options trading volume of 8,173 contracts, representing approximately 817,300 underlying shares, with high volume seen in the $30 strike call option expiring on November 21, 2025.

  • Comparison of Trading Volumes: Both eBay and Option Care Health saw options trading volumes that were around 54% of their respective average daily trading volumes over the past month.

  • Further Information: For additional details on available expirations for options related to AVTR, EBAY, or OPCH, users can visit StockOptionsChannel.com.

Sign Up For More News

People Also Watch

FAQ

arrow icon

What is Option Care Health Inc (OPCH) stock price today?

The current price of OPCH is 29.895 USD — it has decreased -1.21 % in the last trading day.

arrow icon

What is Option Care Health Inc (OPCH)'s business?

Option Care Health, Inc. is an independent provider of home and alternate site infusion services. The Company’s infusion services include the clinical management of infusion therapy, nursing support and care coordination. It provides a therapy portfolio through its network of 92 full-service pharmacies and 93 stand-alone ambulatory infusion suites. It administers a wide variety of therapies and services, including anti-infectives infusion, nutrition support, immunoglobulin infusion, chronic inflammatory disorders, neurological disorders, bleeding disorders infusion, Naven health, women’s health, heart failure, and others. Its home infusion services include medication and supplies for administration and use at home or within one of its ambulatory infusion suites, consultation and education regarding the patient’s condition and the prescribed medication nursing support, clinical monitoring and assistance in monitoring potential side effects, and assistance in obtaining reimbursement.

arrow icon

What is the price predicton of OPCH Stock?

Wall Street analysts forecast OPCH stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for OPCH is 36.43 USD with a low forecast of 27.00 USD and a high forecast of 40.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

arrow icon

What is Option Care Health Inc (OPCH)'s revenue for the last quarter?

Option Care Health Inc revenue for the last quarter amounts to 1.44B USD, increased 12.24 % YoY.

arrow icon

What is Option Care Health Inc (OPCH)'s earnings per share (EPS) for the last quarter?

Option Care Health Inc. EPS for the last quarter amounts to 0.32 USD, increased 3.23 % YoY.

arrow icon

What changes have occurred in the market's expectations for Option Care Health Inc (OPCH)'s fundamentals?

The market is revising Upward the revenue expectations for Option Care Health, Inc. (OPCH) for FY2025, with the revenue forecasts being adjusted by 0.23% over the past three months. During the same period, the stock price has changed by 2.77%.
arrow icon

How many employees does Option Care Health Inc (OPCH). have?

Option Care Health Inc (OPCH) has 6015 emplpoyees as of December 05 2025.

arrow icon

What is Option Care Health Inc (OPCH) market cap?

Today OPCH has the market capitalization of 4.75B USD.

Intellectia LogoIntellectiaIntellectia LogoIntellectia

Redefine Your Investment Decisions

TwitterTwitterYoutubeYoutubeQuoraQuoraDiscordDiscordLinkedinLinkedinTelegramTelegram
AppStoreGooglePlay

Copyright © 2025 Intellectia.AI. All Rights Reserved.

pci certified logo
Company
HomeContactAbout UsNews Release
Compare
TradingViewSeeking Alpha
Features
Financial AI AgentStock Technical AnalysisStock MonitorHedge Fund TrackerAI ScreenerDaytrading Center
Strategies
AI Stock PickerSwing TradingStock Chart PatternsEarnings TradingDaytrading CenterAI Earnings PredictionQuant AIWhales Auto TrackerBacktesting Playground
Free Tools
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Resource
BlogTutorialEarningsTrending StocksCrypto MarketPartner ProgramTerms of UsePrivacy PolicySecuritySitemap
Start for Free